Optimizing Medical Booth Content Display and Poster Events

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Best Practices in Improving Medical Affairs Booth Impact: Information Availability and Poster/Investigator Receptions”

STUDY OVERVIEW

An engaging medical booth presence at major congresses is essential for biopharma companies to effectively showcase their products and research to healthcare professionals (HCPs). However, Medical Affairs teams often face challenges in balancing information availability with compliance requirements, all while designing booth displays that capture attention and encourage interaction.

To explore how leading biopharma companies enhance their medical booth strategies, Best Practices, LLC conducted a benchmarking study focused on optimizing content sharing and display formats, with tailored approaches for both U.S. and EU audiences. Additionally, the study examines the effectiveness of poster presentations and investigator events, providing insights on fostering meaningful engagements with HCPs.

KEY TOPICS

Medical Affairs Booth Content
Display Methods for Medical Booth Content
Approaches to US and EU Content
Poster/Investigator Events at Congresses

KEY METRICS

Top 5 booth content types shared per display method
Content sharing and display formats utilized at medical booths at congresses
Content available at virtual booths, including types and formats shared
Effective interactive elements to enhance engagement at medical affairs booths
Content variations for US, EU, APAC, and other regional audiences at international congresses
Hosting poster/investigator receptions at congresses and content utilized
Re-use of content from previous congresses at poster receptions and the age of materials used
Restrictions on poster/investigator reception attendance at medical congresses

SAMPLE KEY FINDINGS

Medical Booth Content and Display: Disease state and pipeline information are shared with congress attendees by a variety of new and traditional means (e.g., static panels, websites, videos, other interactive media). 90-95% of organizations share this information proactively at booths.

METHODOLOGY

Best Practices, LLC collaborated with 20 leaders in Medical Communications and Scientific Publications from 17 biopharma companies for this comprehensive study. A quantitative survey served as the primary data collection method, supplemented by qualitative insights to enhance the findings.

Industries Profiled:
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Health Care

Companies Profiled:
Amgen; Astellas; Bayer; Chiesi Global Rare Diseases; EMD Serono; Ipsen; Incyte; Morphic Therapeutic; Novartis; OPEN Health; Protagonist Therapeutics; Purdue Pharma; Regeneron; Takeda Pharmaceuticals; Teva Pharmaceuticals; Vertex Pharmaceuticals; Xenon Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Best Practices in Improving Medical Affairs Booth Impact: Information Availability and Poster/Investigator Receptions

ID: 5835

Features:

Pages/Slides: 28

Published: 2024

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
636E837DD2AC24F2A00258BCE0026DF08
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-best-practices-improving-medical-affairs-booth-impact-information-availability-poster-investigator-receptions?opendocument
18
19opendocument
2018.97.9.168
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB